Publicacions - Fundació Institut d'Investigació en Ciències de la

egulatory CD4 (+) CD25(+) CD127(low/-) FoxP3(+) T cells in patients with chronic HCV infection during
pegylated interferon alpha2a plus ribavirin treatment.
J VIRAL HEPATITIS 2010 May 10. doi: 10.1111/j.1365-2893.2010.01317.x. [Epub ahead of print]
IF: 3,502
Travis S, Van Assche G, Dignass A, Cabré E, Gassull MA.
On the second ECCO Consensus on Crohn's disease.J CROHNS COLITIS 2010 Feb;4(1):1-6.
IF: 2,628
Usón J, Sánchez FM, Sória F, Boix J, Fernández M, Latorre R, Climent S, Tejedo V.
Empleo del modelo animal en la formación en endoscopia diagnóstica y terapéutica de la vía biliar
Educ. Med 2010; 13(3): 171-176
Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M, Ochsenkühn T, Orchard T, Rogler
G, Louis E, Kupcinskas L, Mantzaris G, Travis S, Stange E; European Crohn's and Colitis Organisation
(ECCO).(MA Gassull)The second European evidence-based Consensus on the diagnosis and management
of Crohn's disease: Definitionsand diagnosis.
J CROHNS COLITIS 2010 Feb;4(1):7-27. Epub 2010 Jan 15.
IF: 2,628
Van Assche G, Dignass A, Reinisch W, van der Woude CJ, Sturm A, De Vos M, Guslandi M, Oldenburg B,
Dotan I, Marteau P, Ardizzone A, Baumgart DC, D'Haens G, Gionchetti P, Portela F, Vucelic B, Söderholm
J, Escher J, Koletzko S, Kolho KL, Lukas M, Mottet C, Tilg H, Vermeire S, Carbonnel F, Cole A, Novacek G,
Reinshagen M.
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease:
Special situations.
J CROHNS COLITIS 2010 Feb;4(1):63-101. Epub 2009 Dec 21.
IF: 2,628
VanZyl B, Planas R, Ye Y, Foulis AK, deKrijger RR, Butler PC, Nelson JL, Gale EAM, Vives-Pi M, Gillespie KM
Why are levels of maternal microchimerism higher in type 1 diabetes pancreas?
CHIMERISM 2010 Oct;1(2):45-50
Yukihide Momozawa,Myriam Mni,Kayo Nakamura,Wouter Coppieters,Sven Almer,Leila
Amininejad,Isabelle Cleynen,Jean-Frédéric Colombel,Peter de Rijk,Olivier Dewit,Yigael Finkel, Miquel A
Gassull, Dirk Goossens,Debby Laukens,Marc Lémann,Cécile Libioulle,Colm O'Morain,Catherine
Reenaers,Paul Rutgeerts,Curt Tysk,Diana Zelenika,Mark Lathrop,Jurgen Del-Favero,Jean-Pierre
Hugot,Martine de Vos, Denis Franchimont, Severine Vermeire, Edouard Louis & Michel Georges et al.
Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against
inflammatory bowel disease.
NAT GENET 2010; doi:10.1038/ng.733 Received03 August 2010Accepted18 November 2010Published
online12
IF: 36,377
Zabana Y, Domènech E, Mañosa M, Garcia-Planella E, Bernal I, Cabré E, Gassull MA.
Infliximab safety profile and long-term applicability in inflammatory bowel disease: 9-year experience in
clinical practice.
ALIMENT PHARM THER 2010 Mar;31(5):553-60. Epub 2009 Nov 30.
IF: 3,861
Zeuzem S, Sulkowski MS, Lawitz EJ, Rustgi VK, Rodriguez-Torres M, Bacon BR, Grigorescu M, Tice AD,
Pàgina 20 de 148